Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”
Data publikacji online: 2017/09/30
Pobierz cytowanie
AMA
. Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”. Folia Neuropathologica. 2017;55(3):249-281. doi:10.5114/fn.2017.70491.
APA
. (2017). Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”. Folia Neuropathologica, 55(3), 249-281. https://doi.org/10.5114/fn.2017.70491
Chicago
. 2017. "Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”". Folia Neuropathologica 55 (3): 249-281. doi:10.5114/fn.2017.70491.
Harvard
. (2017). Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”. Folia Neuropathologica, 55(3), pp.249-281. https://doi.org/10.5114/fn.2017.70491
MLA
. "Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”." Folia Neuropathologica, vol. 55, no. 3, 2017, pp. 249-281. doi:10.5114/fn.2017.70491.
Vancouver
. Neurochemical Conference 2017: “Advances in molecular and epigenetic mechanisms
in neurodegeneration and neuroinflammation: novel therapeutic approaches”. Folia Neuropathologica. 2017;55(3):249-281. doi:10.5114/fn.2017.70491.
Copyright: © 2017 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
http://creativecommons.org/licenses/by-nc-sa/4.0/ ), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
